Clinical Highlights in Uveal Melanoma
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 25 November 2025 | Viewed by 42
Special Issue Editors
Interests: corneal; ocular trauma
Interests: eye diseases; cataract
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The progress made regarding uveal melanoma therapy in recent years is noticeable. The availability of and advances made in the development of diagnostic and visualization devices has improved diagnostics. New strategies and improvements in radiotherapy and surgery techniques have enhanced treatment outcomes. The application of artificial intelligence offers hope for the better recognition of the disease and its prognosis. Clinical and laboratory observations along with basic science experiments help us to better understand the nature of the disease; however, uveal melanoma is still the most common primary intraocular tumor in adults, constituting a cause of visual impairment, blindness and even death. In this Special Issue, we welcome authors to submit papers on the clinical highlights in uveal melanoma, which will ensure that knowledge of this serious and challenging condition is up to date.
Dr. Tomasz Chorągiewicz
Dr. Joanna Dolar-Szczasny
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- choroidal melanoma
- uveal melanoma
- radiotherapy
- enucleation
- brachytherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
